This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Jörg Kroll: Innovator in Pharmaceutical Chemistry
Introduction
Jörg Kroll is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry. His work focuses on innovative compounds that have the potential to treat various diseases.
Latest Patents
Jörg Kroll holds a patent for "Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents." This patent describes the production of these derivatives, as well as intermediate products for their production. The compounds are intended for use as pharmaceutical agents in treating a range of diseases.
Career Highlights
Kroll is associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work there has been instrumental in advancing the development of new therapeutic agents. He has a strong focus on creating innovative solutions that address unmet medical needs.
Collaborations
Throughout his career, Jörg Kroll has collaborated with several professionals in the field, including Martin Krüger and Olaf Prien. These collaborations have enhanced his research and contributed to the success of his projects.
Conclusion
Jörg Kroll's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key figure in the industry. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile